How a Dutch AI Startup Is Quietly Transforming Hearing Care Access

Jan de Vries · 2026-08-28

There's a quiet revolution happening in hearing care, and it's coming from a startup in Maastricht, Netherlands. Clementine, a company founded just this year, has secured $2 million in Seed funding to scale its unique approach. They're not just building another AI tool; they're trying to solve a massive human problem that leaves millions waiting for help. Let's talk about that problem for a second. Hearing loss affects a staggering 1.5 billion people globally. But here's the kicker: nearly 80% of those people never actually seek treatment. And for those who do muster the courage? They often wait more than eight years before taking that first step. That's a lifetime of missed conversations and connections. ### The AI Agent Bridging the Gap Clementine's solution is built around a digital agent named Matthew. Think of Matthew not as a cold chatbot, but as a patient, knowledgeable guide available 24/7. This AI hearing care agent is designed to do what overwhelmed clinic staff can't always manage: answer every single inquiry without judgment, without a waiting list, and at the exact moment a person is curious or concerned. It tackles the emotional and practical barriers that keep people from seeking care. Maybe someone is embarrassed. Maybe they're unsure if their issue is 'bad enough.' Matthew meets them right there, providing education and gentle guidance toward the appropriate next steps. "Clinics don't need more leads; they need better conversations at the right moment," explains Vince van de Weijer, Clementine's founder and CEO. "Matthew ensures no patient inquiry goes unanswered." ### Why Investors Are Listening Closely The $2 million Seed round was led by Healthy.Capital, an Amsterdam-based investor known for backing innovative HealthTech companies. Their confidence isn't just in the technology, but in the potential for systemic change. Douwe Jippes, managing partner at Healthy.Capital, put it this way: "Clementine combines deep domain expertise with a clear AI platform strategy that can scale globally. We believe this approach will fundamentally change how people with hearing disability engage with healthcare." For clinics, the value proposition is clear. Matthew handles the initial administrative heavy lifting—answering common questions, scheduling appointments—freeing up human staff for more complex, high-value interactions. It turns vague interest into concrete bookings. ### A Strategic Push into North America This funding arrives at a pivotal time. Clementine isn't just thinking about Europe. They've already expanded their commercial footprint through a key partnership with Zoolstra, a marketing agency that serves hearing clinics and groups across the United States and Canada. This move signals a clear intent to tackle the massive North American market, where access issues and clinic inefficiencies are just as prevalent. The fresh capital will be used to deepen the AI's capabilities and forge more partnerships, not just with hearing clinics, but with optical retailers and other healthcare organizations. The vision is to integrate this judgment-free entry point into healthcare wherever it makes sense. It's a fascinating case of using technology not to replace human care, but to make it more accessible. By pairing AI with behavioral science, Clementine is building a bridge. A bridge that helps people cross over from isolation to connection, one conversation at a time. And that's an outcome worth investing in.